Bio Essence Corporation

BIOE

US09090C1053

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:22:14 2024-01-23 pm EST			5-day change	1st Jan Change
0.26 ^USD	-49.02%		-.--%	-49.02%

Apr. 15	Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 04	Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation on for $0.4 million	CI

Bio Essence Corporation Announces Resignation of Sharon Mair from the Board of Directors

December 13, 2023 at 03:50 pm EST

On December 8, 2023, Bio Essence Corporation received notice from Sharon Mair, a member of the Company?s Board of Directors, that she resigned from the Board of Directors effective immediately.

Latest news about Bio Essence Corporation

Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15	CI
Health Up, Inc acquired Bio Essence Herbal Essentials, Inc. from Bio Essence Corporation on for $0.4 million	Apr. 03	CI
Newways, Inc. completed the acquisition of Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation.	Dec. 30	CI
Bio Essence Corporation Announces Resignation of Sharon Mair from the Board of Directors	Dec. 13	CI
Newways, Inc. agreed to acquire Bio Essence Pharmaceutical, Inc. from Bio Essence Corporation for $0.3 million.	Dec. 12	CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Bio Essence Corporation Appoints William E. Sluss as Chief Financial Officer	23-09-07	CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	23-03-29	CI
Bio Essence Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Bio Essence Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Bio Essence Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Bio Essence Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Bio Essence Corporation Auditor Raises 'Going Concern' Doubt	22-03-30	CI

Bio Essence Corp. is a herbal health, diet, and nutrition company. The Company operates through its subsidiaries, including Bio Essence Pharmaceutical, Inc. (BEP), Bio Essence Herbal Essentials Inc. (BEH), and McBE Pharma, Inc. (McBE). The primary focus of BEP is producing products for BEH and McBE, along with providing original equipment manufacturing and private label services to other companies. BEH targets and develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offers special formulated dietary supplements and medical food. The Company sells its products through channels, such as TCM practitioners, online Websites, including its own Website, and brick-and-mortar stores, such as GNC. The Company also focuses on providing customers direct connections with integrative healthcare practitioners such as dietitians, nutraceutical practitioners, and other practitioners in this discipline worldwide.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
BIO ESSENCE CORPORATION	-49.02%	9.88M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+26.67%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+14.77%	231B
NOVARTIS AG	+5.24%	200B
ROCHE HOLDING AG	-8.79%	195B
AMGEN INC.	-6.26%	145B